suPARnostic® is the only CE-IVD certified product range applied for clinical assessment of suPAR levels in human plasma and serum. 

Implementing suPARnostic® enables healthcare professionals to make fast clinical decisions based on prognostic evidence across diseases.

Help reduce crowding, stress, hospital costs and improve patient outcomes

Support your hospital’s initiative to reduce crowding, the stress of hospital staff, healthcare costs and improve patient outcomes by introducing the suPARnostic® biomarker test in your laboratory.

suPARnostic® TurbiLatex is validated for all major automated clinical chemistry analyzers and fits existing hospital workflows, enabling seamless implementation in clinical biochemistry departments and core laboratories.

How to interpret suPAR results

High quality results in minutes

A short turnaround time is key to optimizing clinical decision making and allowing timely patient care. suPARnostic® can improve the patient turnaround time and provide highquality prognostic results.

A suPAR level <4 ng/mL indicates a good prognosis and supports the decision to discharge the patient.

A suPAR level >6 ng/mL indicates the presence, progression, and severity of disease, organ damage, and mortality risk and supports further clinical attention.

Documented by 700+ publications

Here you can find a short summary of the research done on suPAR within 12 groups of disease areas and see how the suPAR level is affected within each type of disease.

“The key challenge for the emergency department is to identify ill patients faster, make diagnoses faster, find the right specialist faster and initiate the right treatment faster.”

MD, Chief Physician Inger Søndergaard, Herlev Hospital, Copenhagen

Early anakinra treatment of COVID-19 patients guided by suPAR saves lives

Get our whitepaper about the study results and read more about how an early start of anakinra treatment guided by suPAR provides 2.78 times better improvement of overall clinical status in moderate and severe COVID-19 pneumonia.


published suPAR studies in leading medical journals

The suPARnostic® brand consists of 3 products:

Photo of The suPARnostic® Quick Triage kit

Quick Triage

A Point of Care Solution

Photo of suPARnostic® TurbiLatex


For Automated Systems

Photo of suPARnostic® ELISA


Clinical and Research

Would you like to know more?

If you have any questions regarding our products or business, write to us here

Thank you!

You'll hear from us shortly.

An error occured!

Please try again, or contact us by e-mail if the problem persist.

Sign up for our newsletter

By signing up for our newsletter you will receive the latest news about our products.

Thank you!

You'll hear from us shortly.

An error occured!

Please try again, or contact us by e-mail if the problem persist.

New Webinar


Catch COVID-19

-Improve your triage

Sign up to view webinar recording

View recording

suPARnostic® by ViroGates